Internship

Molecular Interactions Intern

Posted on 11/15/2024

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

Biotechnology
Healthcare

Compensation Overview

CA$19.04 - CA$21.35Hourly

Vancouver, BC, Canada

This is an on-site position based in Vancouver.

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Currently pursuing a Bachelor’s degree in a relevant field, such as Biochemistry or Biology
  • Solid understanding of protein biochemistry
  • Knowledge of/interest in analytical and biophysical techniques
  • Previous experience operating in a wet lab environment
  • Self-motivated with initiative and drive to meet goals under project timelines
  • Excellent documentation, organizational, and communication skills with impeccable attention to detail
  • Ability to function effectively as part of a team
Responsibilities
  • Learning and applying lab techniques such as surface plasmon resonance (SPR) or biolayer interferometry (BLI) to support antibody drug discovery programs
  • Learning about antibody drug discovery and development, and antibody-antigen interactions
  • Contributing to method development, optimization, and troubleshooting
  • Collaborating with teammates to solve problems, analyze, interpret and communicate data
  • Performing literature review for experiments
  • Participating and presenting in team meetings

AbCellera specializes in discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera focuses on challenging targets that traditional methods struggle to address. The company aims to accelerate the development of new medicines through collaborations, generating revenue from discovery services, licensing agreements, and its own therapeutic programs.

Company Stage

Grant

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

31%
Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic collaborations with firms like Viking Global Investors and Biogen expand AbCellera's capabilities and market opportunities.
  • AbCellera's participation in high-profile industry conferences and presentations, such as AACR, showcases its cutting-edge research and strengthens its industry reputation.
  • The company's internal pipeline of therapeutic programs offers potential for significant breakthroughs and new treatments.

What critics are saying

  • The highly competitive and rapidly evolving biopharmaceutical market requires continuous innovation to maintain a competitive edge.
  • The recent resignation of board member Peter Thiel could lead to strategic and governance challenges.

What makes AbCellera Biologics unique

  • AbCellera's proprietary technology platform accelerates antibody discovery, making it faster and more efficient than traditional methods.
  • The company's ability to tackle challenging targets that have been difficult to address with traditional methods sets it apart in the biopharmaceutical market.
  • AbCellera's collaborative business model, which includes partnerships with leading investment firms and biotech companies, enhances its innovation and market reach.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE